These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20841937)

  • 1. [Optic lesions in patients with epiphora during S-1 therapy].
    Shibahara H; Kuze S; Kyokane T; Takamizawa J; Nakamura H; Atsumi H
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1735-9. PubMed ID: 20841937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of epiphora following S-1 therapy].
    Kitamura H; Miyanaga T; Shin H; Fujita M; Miyazaki M; Yagi D; Ito H; Asaumi Y; Hirano Y; Hayashida Y; Maeda K; Ota K; Hayashi H; Douden K; Hattori M; Hashidume Y; Sasaki T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):259-62. PubMed ID: 21368490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
    Esmaeli B; Golio D; Lubecki L; Ajani J
    Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the efficacy of probing the nasolacrimal duct as a treatment for epiphora in adults.
    Bell TA
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 4)():494-7. PubMed ID: 3466472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double lacrimal puncta: clinical presentation and potential mechanisms of epiphora.
    Satchi K; McNab AA
    Ophthalmology; 2010 Jan; 117(1):180-183.e2. PubMed ID: 19875171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Causes of epiphora in diagnosed and treated patients in Department of Ophthalmology in Military Institute of Health Service].
    Rózycki R; Jakubaszek A; Maliborski A
    Klin Oczna; 2009; 111(10-12):319-22. PubMed ID: 20169886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
    Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous administration and safety of S-1 in adjuvant chemotherapy for gastric cancer].
    Kimura M; Morihata K; Ito D; Iwai M; Okada K; Usami E; Nakao T; Yoshimura T; Yasuda T
    Gan To Kagaku Ryoho; 2010 May; 37(5):829-34. PubMed ID: 20495311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1.
    Moriya K; Shimizu H; Handa S; Sasaki T; Sasaki Y; Takahashi H; Nakamura S; Yoshida H; Kato Y
    Gan To Kagaku Ryoho; 2017 Jun; 44(6):501-506. PubMed ID: 28698442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
    Nomura T; Murakami R; Toya R; Teshima K; Nakahara A; Hirai T; Hiraki A; Nakayama H; Yoshitake Y; Ota K; Obayashi T; Yamashita Y; Oya N; Shinohara M
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1347-52. PubMed ID: 19628343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributing factors to prevent prolonged epiphora after maxillectomy.
    Yeo NK; Wang JH; Chung YS; Jang YJ; Lee BJ
    Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):229-33. PubMed ID: 20231638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].
    Matsui K; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Takii Y; Tsuchiya Y; Tanaka O
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):953-7. PubMed ID: 19542714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lacrimal duct obstruction treated with lacrimonasal stent].
    Soler Machín J; Castillo Laguarta JM; De Gregorio Ariza MA; Medrano J; Cristóbal Bescós JA
    Arch Soc Esp Oftalmol; 2003 Jun; 78(6):315-8. PubMed ID: 12838463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.
    Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):335-43. PubMed ID: 17922276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems of adjuvant chemotherapy with S-1 for gastric cancer].
    Teshima S; Saito T; Endo A; Yunome G; Harada A; Ooshio H; Kodama H; Takeda K; Kikuchi S
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):255-8. PubMed ID: 20154480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
    Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dacryoendoscopic observation and incidence of canalicular obstruction/stenosis associated with S-1, an oral anticancer drug.
    Sasaki T; Miyashita H; Miyanaga T; Yamamoto K; Sugiyama K
    Jpn J Ophthalmol; 2012 May; 56(3):214-8. PubMed ID: 22411166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
    Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
    J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
    Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.